Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer
Related Experiment Video
Updated: Feb 8, 2026

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Published on: November 5, 2021
Gang Chen1, Yixin Wang1, Pengkai Wu1
1State Key Laboratory of Natural Medicines, Department of Pharmaceutics , China Pharmaceutical University , Nanjing 210009 , China.
Abstract:
Metastatic breast cancer is a major cause of cancer-related female mortality worldwide. The signal transducer and activator of transcription 3 (STAT3) and the chemokine receptor CXCR4 are involved in the metastatic spread of breast cancer. The goal of this study was to develop nanomedicine treatment based on combined inhibition of STAT3 and CXCR4. We synthesized a library of CXCR4-inhibiting polymers with a combination of beneficial features that included PEGylation, fluorination, and bioreducibility to achieve systemic delivery of siRNA to silence STAT3 expression in the tumors. An in vivo structure-activity relationship study in an experimental lung metastasis model revealed superior antimetastatic activity of bioreducible fluorinated polyplexes when compared with nonreducible controls despite similar CXCR4 antagonism and the ability to inhibit in vitro cancer cell invasion. When compared with nonreducible and nonfluorinated polyplexes, improved siRNA delivery was observed with the bioreducible fluorinated polyplexes. The improvement was ascribed to a combination of enhanced physical stability, decreased serum destabilization, and improved intracellular trafficking. Pharmacokinetic analysis showed that fluorination decreased the rate of renal clearance of the polyplexes and contributed to enhanced accumulation in the tumors. Therapeutic efficacy of the polyplexes with STAT3 siRNA was assessed in early stage breast cancer and late-stage metastatic breast cancer with primary tumor resection. Strong inhibition of the primary tumor growth and pronounced antimetastatic effects were observed in both models of metastatic breast cancer. Mechanistic studies revealed multifaceted mechanism of action of the combined STAT3 and CXCR4 inhibition by the developed polyplexes relying both on local and systemic effects.
Insights
New nanomedicine effectively targets both STAT3 and CXCR4 pathways, significantly inhibiting metastatic breast cancer growth and spread. This combined approach shows promise for treating advanced breast cancer with improved tumor accumulation and delivery.
Area of Science:
- Oncology
- Nanomedicine
- Molecular Biology
Background:
- Metastatic breast cancer is a leading cause of cancer mortality in women globally.
- Signal transducer and activator of transcription 3 (STAT3) and chemokine receptor CXCR4 are key drivers of breast cancer metastasis.
- Targeting these pathways offers a potential therapeutic strategy.
Purpose of the Study:
- To develop a novel nanomedicine for combined inhibition of STAT3 and CXCR4 in metastatic breast cancer.
- To synthesize and characterize CXCR4-inhibiting polymers for systemic siRNA delivery to silence STAT3.
- To evaluate the therapeutic efficacy and mechanism of action of the developed nanomedicine.
Main Methods:
- Synthesis of PEGylated, fluorinated, and bioreducible polymers for polyplex formation with siRNA.
- In vivo structure-activity relationship studies in a lung metastasis model.
- In vitro cancer cell invasion assays.
- Pharmacokinetic analysis and biodistribution studies.
- Assessment of therapeutic efficacy in early-stage and late-stage metastatic breast cancer models.
Main Results:
- Bioreducible fluorinated polyplexes demonstrated superior antimetastatic activity compared to nonreducible controls.
- Improved siRNA delivery, physical stability, serum stability, and intracellular trafficking were observed with bioreducible fluorinated polyplexes.
- Fluorination enhanced polyplex accumulation in tumors by reducing renal clearance.
- Combined STAT3 and CXCR4 inhibition led to significant primary tumor growth inhibition and pronounced antimetastatic effects in both tested models.
- Mechanistic studies indicated a multifaceted mechanism involving both local and systemic effects.
Conclusions:
- Developed bioreducible, fluorinated polyplexes effectively deliver STAT3 siRNA for combined STAT3 and CXCR4 inhibition.
- This nanomedicine approach shows significant therapeutic potential against metastatic breast cancer.
- The findings support further investigation of this dual-targeting strategy for clinical translation.
More Related Videos
05:05Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Treatment Resistant Cancers
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Stability
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...
Stages of Infection
Reversible and Irreversible Processes